Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA TTK HEALTHCARE AJANTA PHARMA/
TTK HEALTHCARE
 
P/E (TTM) x 27.7 70.3 39.4% View Chart
P/BV x 6.8 1.8 389.5% View Chart
Dividend Yield % 0.5 0.9 58.6%  

Financials

 AJANTA PHARMA   TTK HEALTHCARE
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
TTK HEALTHCARE
Mar-19
AJANTA PHARMA/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,4221,215 117.0%   
Low Rs898610 147.1%   
Sales per share (Unadj.) Rs233.5444.4 52.6%  
Earnings per share (Unadj.) Rs44.017.2 254.9%  
Cash flow per share (Unadj.) Rs52.227.6 188.8%  
Dividends per share (Unadj.) Rs9.005.00 180.0%  
Dividend yield (eoy) %0.80.5 141.6%  
Book value per share (Unadj.) Rs255.1177.9 143.4%  
Shares outstanding (eoy) m88.0214.13 622.9%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x5.02.1 241.8%   
Avg P/E ratio x26.452.9 49.9%  
P/CF ratio (eoy) x22.233.0 67.3%  
Price / Book Value ratio x4.55.1 88.7%  
Dividend payout %20.529.0 70.6%   
Avg Mkt Cap Rs m102,08112,894 791.7%   
No. of employees `0006.82.3 294.1%   
Total wages/salary Rs m4,3071,307 329.5%   
Avg. sales/employee Rs Th3,022.62,715.7 111.3%   
Avg. wages/employee Rs Th633.4565.3 112.0%   
Avg. net profit/employee Rs Th569.1105.4 539.9%   
INCOME DATA
Net Sales Rs m20,5546,279 327.4%  
Other income Rs m21178 272.0%   
Total revenues Rs m20,7656,356 326.7%   
Gross profit Rs m5,664496 1,142.9%  
Depreciation Rs m721147 491.3%   
Interest Rs m1234 34.3%   
Profit before tax Rs m5,143393 1,309.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,273149 854.9%   
Profit after tax Rs m3,870244 1,587.9%  
Gross profit margin %27.67.9 349.1%  
Effective tax rate %24.837.9 65.3%   
Net profit margin %18.83.9 485.1%  
BALANCE SHEET DATA
Current assets Rs m11,8122,717 434.7%   
Current liabilities Rs m3,7761,571 240.4%   
Net working cap to sales %39.118.3 214.1%  
Current ratio x3.11.7 180.8%  
Inventory Days Days7732 240.6%  
Debtors Days Days8247 174.9%  
Net fixed assets Rs m14,398991 1,452.9%   
Share capital Rs m175141 124.1%   
"Free" reserves Rs m22,2772,373 938.8%   
Net worth Rs m22,4522,514 893.0%   
Long term debt Rs m73 194.1%   
Total assets Rs m26,9624,158 648.4%  
Interest coverage x444.312.6 3,522.2%   
Debt to equity ratio x00 21.7%  
Sales to assets ratio x0.81.5 50.5%   
Return on assets %14.46.7 215.7%  
Return on equity %17.29.7 177.8%  
Return on capital %23.016.9 135.5%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m10,682225 4,743.2%   
Fx outflow Rs m2,10271 2,955.8%   
Net fx Rs m8,580154 5,568.0%   
CASH FLOW
From Operations Rs m3,748173 2,165.1%  
From Investments Rs m-2,22897 -2,308.8%  
From Financial Activity Rs m-1,475-307 479.9%  
Net Cashflow Rs m45-38 -119.9%  

Share Holding

Indian Promoters % 73.8 65.4 112.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 3.7 41.9%  
FIIs % 7.6 5.2 146.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 25.8 65.9%  
Shareholders   20,968 12,723 164.8%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   VENUS REMEDIES  NEULAND LABS  PIRAMAL ENTERPRISES  FDC  SHASUN PHARMA  

Compare AJANTA PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

SGX Nifty Down 38 Points; Indicates Negative Opening for Indian Stock Markets(SGX Nifty)

The SGX Nifty opened on a negative note today. At 8:00 am, it was trading down by 38 points, or 0.27% lower at 14,420 levels.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 60.8% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 60.8% YoY). Sales on the other hand came in at Rs 7 bn (up 34.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Jan 15, 2021 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 8-QTR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS